IP Library › Assignment 023973/0200
Patent Assignment
Reel/Frame 023973/0200

Change of Name

Recorded: 2010-02-22 Received: 2010-02-23 Pages: 4
Assignor
DEGUSSA GMBH
Executed: 2007-09-12
Assignee
EVONIK DEGUSSA GMBH
BENNIGSENPLATZ 1, DUSSELDORF, DEX, 40474, GERMANY
Covered Properties (97)
Usirna Complexes
Amino Acid-Based Nanoparticle Formulations
Application: 61/258,115 →
Processes and Compositions for Liposomal and Efficient Delivery of Gene Silencing Therapeutics
Rna Complexes Comprising Acyclic Nucleomonomers
Application: 61/252,085 →
Nucleic Acid Compounds for Inhibiting Gene Expression and Uses Thereof
Application: 12/552,082 →
Nucleic Acid Compounds for Inhibiting Wnt Gene Expression and Uses Thereof
Application: 12/529,532 →
Nucleic Acid Compounds for Inhibiting Ras Gene Expression and Uses Thereof
Application: 12/529,302 →
Nucleic Acid Compounds for Inhibiting Myc Gene Expression and Uses Thereof
Application: 12/529,138 →
Nucleic Acid Compounds for Inhibiting BCL2 Gene Expression and Uses Thereof
Application: 12/529,011 →
Nucleic Acid Compounds for Inhibiting HIF1A Gene Expression and Uses Thereof
Application: 12/528,786 →
Nucleic Acid Compounds for Inhibiting Erbb Family Gene Expression and Uses Thereof
Application: 12/528,619 →
Nucleic Acid Compounds for Inhibiting Vegf Family Gene Expression and Uses Thereof
Application: 12/528,508 →
Nucleic Acid Compounds for Inhibiting BIRC5 Gene Expression and Uses Thereof
Nucleic Acid Compounds for Inhibiting PLK1 Gene Expression and Uses Thereof
Hydroxymethyl Substituted Rna Oligonucleotides and Rna Complexes
Application: 12/515,403 →
Compositions and Methods for Efficient Delivery of Gene Silencing Therapeutics
Application: 61/167,379 →
Rna Oligonucleotides and Rna Complexes Comprising Acyclic Nucleomonomers
Application: 61/119,624 →
Compositions and Methods for Liposomal Rna Therapeutics
Application: 61/106,062 →
Lipopeptides for Delivery of Nucleic Acids
Compositions and Methods for Enhancing Delivery of Nucleic Acids into Cells and for Modifying Expression of Target Genes in Cells
Application: 12/206,165 →
Nucleic Acid Compounds for Inhibiting PLK1 Gene Expression and Uses Thereo
Application: 61/086,445 →
Nucleic Acid Compounds for Inhibiting BIRC5 Gene Expression and Uses Thereof
Application: 61/086,435 →
Hydroxymethyl Substituted Rna Oligonucleotides and Rna Complexes
Amino Acid Lipids and Uses Thereof
Nucleic Acid Compounds for Inhibiting Myc Gene Expression and Uses Thereof
Nucleic Acid Compounds for Inhibiting Wnt Gene Expression and Uses Thereof
Nucleic Acid Compounds for Inhibiting Ras Gene Expression and Uses Thereof
Nucleic Acid Compounds for Inhibiting BCL2 Gene Expression and Uses Thereof
Nucleic Acid Compounds for Inhibiting Vegf Gene Expression and Uses Thereof
Application: 12/039,650 →
Nucleic Acid Compounds for Inhibiting Apob Gene Expression and Uses Thereof
Application: 12/039,668 →
Nucleic Acid Compounds for Inhibiting Vegf Family Gene Expression and Uses Thereof
Nucleic Acid Compounds for Inhibiting Akt Gene Expression and Uses Thereof
Application: 12/039,662 →
Nucleic Acid Compounds for Inhibiting Erbb Gene Expression and Uses Thereof
Application: 12/039,658 →
Nucleic Acid Compounds for Inhibiting HIF1A Gene Expression and Uses Thereof
Nucleic Acid Compounds for Inhibiting Akt Gene Expression and Uses Thereof
Dispersion Compositions for Interfering Rna and Uses Thereof
Application: 61/022,571 →
Nucleic Acid Compounds for Inhibiting WNT3A Gene Expression and Uses Thereof
Application: 61/015,611 →
Nucleic Acid Compounds for Inhibiting AKT3 Gene Expression and Uses Thereof
Application: 61/013,239 →
Nucleic Acid Compounds for Inhibiting AKT2 Gene Expression and Uses Thereof
Application: 61/013,212 →
Phage Displayed Trp Cage Ligands
Application: 11/955,207 →
Nucleic Acid Compounds for Inhibiting BCL2 Gene Expression and Uses Thereof
Application: 60/989,419 →
Nucleic Acid Compounds for Inhibiting Nras Gene Expression and Uses Thereof
Application: 60/988,400 →
Nucleic Acid Compounds for Inhibiting Kras Gene Expression and Uses Thereof
Application: 60/988,402 →
Nucleic Acid Compounds for Inhibiting Myc Gene Expression and Uses Thereof
Application: 60/988,395 →
Nucleic Acid Compounds for Inhibiting Hras Gene Expression and Uses Thereof
Application: 60/988,401 →
Nicked or Gapped Nucleic Acid Molecules and Uses Thereof
Lipopeptides for Delivery of Interfering Rna Agents
Application: 60/976,894 →
Nucleic Acid Compounds for Inhibiting AKT1 Gene Expression and Uses Thereof
Application: 60/973,398 →
Nucleic Acid Compounds for Inhibiting RAF1 Gene Expression and Uses Thereof
Application: 60/973,397 →
Emulsion Compositions for Interfering Rna and Uses Thereof
Application: 60/972,590 →
Amino Acid Lipids and Uses for Rna Therapeutics
Application: 60/972,653 →
Nucleic Acid Compounds for Inhibiting HIF1A Gene Expression and Uses Thereof
Application: 60/956,093 →
Compositions and Methods of Using Double-Stranded Nucleic Acid Molecules Containing One or More Gap or Nick
Application: 60/955,317 →
Amino Acid Lipid Compositions and Methods for Delivering Rna Therapeutics
Application: 60/953,667 →
Amino Acid Lipid Compositions and Methods for Delivering Rna Therapeutics
Application: 60/947,282 →
Nucleic Acid Compounds for Inhibiting Erbb Family Gene Expression and Uses Thereof
Application: 60/932,970 →
Nucleic Acid Compounds for Inhibiting ERBB4 Gene Expression and Uses Thereof
Application: 60/934,922 →
Nucleic Acid Compounds for Inhibiting ERBB3 Gene Expression and Uses Thereof
Application: 60/934,935 →
Nucleic Acid Compounds for Inhibiting Egfr Gene Expression and Uses Thereof
Application: 60/934,945 →
Amino Acid Lipid Compositions and Methods for Delivering Rna Therapeutics
Application: 60/916,131 →
Nucleic Acid Compounds for Inhibiting ERBB2 Gene Expression and Uses Thereof
Application: 60/934,946 →
Nucleic Acid Compounds for Inhibiting Vegf Family Gene Expression and Uses Thereof
Application: 60/932,949 →
Nucleic Acid Compounds for Inhibiting Figf Gene Expression and Uses Thereof
Application: 60/934,943 →
Nucleic Acid Compounds for Inhibiting Pgf Gene Expression and Uses Thereof
Application: 60/934,934 →
Nucleic Acid Compounds for Inhibiting Vegfb Gene Expression and Uses Thereof
Application: 60/934,928 →
Nucleic Acid Compounds for Inhibiting Vegf Gene Expression and Uses Thereof
Application: 60/934,931 →
Compositions and Methods of Using Gapped or Nicked Double Stranded Nucleic Acid Molecules
Application: 60/910,393 →
Method of Treating an Inflammatory Disease by Double Stranded Ribonucleic Acid
Application: 11/576,139 →
Compounds for Inhibiting Gene Expression by Ribonucleic Acid Interference and Uses Thereof
Application: 60/934,930 →
Compounds for Inhibiting Tnf Gene Expression by Ribonucleic Acid Interference and Uses Thereof
Application: 60/934,940 →
Phage Displayed Cell Binding Peptides
Application: 11/627,863 →
COMPOSITIONS AND METHODS EMPLOYING GAPPED OR NICKED siRNA MOLECULES
Application: 60/862,027 →
Compounds and Methods for Peptide Ribonucleic Acid Condensate Particles for Rna Therapeutics
Phage Displayed Cell Binding Peptides
Application: 60/823,894 →
Phage displayed cell binding peptides
Application: 60/774,496 →
Peptide mediated cellular uptake of double stranded RNA
Application: 60/733,664 →
Peptide-mediated sirna uptake into cells
Application: 60/727,216 →
Method of Treating an Inflammatory Disease by Double Stranded Ribonucleic Acid
Compositions and Methods for Enhancing Delivery of Nucleic Acids into Cells and for Modifying Expression of Target Genes in Cells
Methods and Compositions for Enhancing Delivery of Double-Stranded Rna or a Double-Stranded Hybrid Nucleic Acid to Regulate Gene Expression in Mammalian Cells
Compositions and methods for RNA interference to treat rheumatoid arthritis
Application: 60/667,833 →
Conjugation or complexation of a protein transduction domain and fusogenic polypeptide to a small interfering nucleic acid for use in RNA interference
Application: 60/656,572 →
Phage Displayed Trp Cage Ligands
Application: 10/976,942 →
Use of RNA interference to treat rheumatoid arthritis
Application: 60/613,416 →
Polylpeptides complexed or linked to double-stranded RNA or to an RNA/DNA hybrid with a cationic lipid
Application: 60/570,512 →
Polylpeptides complexed or covalently bonded to double-stranded RNA or to an RNA/DNA hybrid
Application: 60/570,513 →
Histones complexed or covalently bonded to double-stranded RNA to an RNA/DNA hybrid
Application: 60/568,027 →
Conjugation of a cholesterol moiety to double-stranded RNA or a double-stranded hybrid nucleic acid
Application: 60/564,543 →
Furnace carbon black, process for production and use thereof
Application: 10/793,734 →
Phage displayed Trp cage ligands
Application: 60/515,533 →
Nanoparticles for delivery of nucleic acids and stable double-stranded RNA
Application: 60/497,740 →
Compact Bidirectional Repeaters for Wireless Communication Systems
Application: 10/640,224 →
Nucleotide Sequences Coding for the Glk-Gene
Application: 10/197,541 →
Operational Support System for Telecommunication Services
Application: 10/097,864 →
Recombinant L-N-Carbamoylase from Arthrobacter Aurescens and Method of Producing L-Amino Acids Therewith
Application: 10/045,063 →
Aqueous Lysine-Containing Animal Feed Supplements and Process for the Production Thereof
Application: 10/026,959 →
Process for the Preparation of 3-Amino-2-Oxo-Pyrrolidines, Novel Intermediates and Their Use
Application: 10/005,817 →